Paper36979345
Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure.
Screever EM and 8 others. Biomolecules, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure. Papers, record 36979345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979345
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathies | Major topic |
| Heart Failure | Major topic |
| Animals | |
| Mice | |
| Biomarkers | |
| Cicatrix | |
| Contrast Media | |
| Fibrosis | |
| Gadolinium | |
| Galectin 3 | |
| Magnetic Resonance Imaging | |
| Humans | |
| Blood Proteins | |
| Galectins |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29459363 | Heart Failure Stimulates Tumor Growth by Circulating Factors. | Circulation | 2018 | https://conductscience.org/library/papers/29459363 | PubMed |
| 2 | 35076018 | Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy. | Elife | 2022 | https://conductscience.org/library/papers/35076018 | PubMed |
| 3 | 35147665 | Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis. | Eur Heart J Cardiovasc Imaging | 2022 | https://conductscience.org/library/papers/35147665 | PubMed |
| 4 | 17112987 | Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. | J Am Coll Cardiol | 2006 | https://conductscience.org/library/papers/17112987 | PubMed |
| 5 | 10471456 | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10471456 | PubMed |
| 6 | 21242479 | Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. | Circulation | 2011 | https://conductscience.org/library/papers/21242479 | PubMed |
| 7 | 26762873 | T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. | JACC Cardiovasc Imaging | 2016 | https://conductscience.org/library/papers/26762873 | PubMed |
| 8 | 27084804 | Serial galectin-3 and future cardiovascular disease in the general population. | Heart | 2016 | https://conductscience.org/library/papers/27084804 | PubMed |
| 9 | 16549783 | Galectin-3 regulates myofibroblast activation and hepatic fibrosis. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16549783 | PubMed |
| 10 | 34385704 | Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. | Nat Med | 2021 | https://conductscience.org/library/papers/34385704 | PubMed |
| 11 | 29447739 | Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29447739 | PubMed |
| 12 | 15236377 | Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. | Magn Reson Med | 2004 | https://conductscience.org/library/papers/15236377 | PubMed |
| 13 | 26466857 | Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH. | Eur J Heart Fail | 2015 | https://conductscience.org/library/papers/26466857 | PubMed |
| 14 | 27461364 | Galectin-3, Cardiac Function, and Fibrosis. | Am J Pathol | 2016 | https://conductscience.org/library/papers/27461364 | PubMed |
| 15 | 35511857 | Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35511857 | PubMed |
| 16 | 25637629 | Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. | Circulation | 2015 | https://conductscience.org/library/papers/25637629 | PubMed |
| 17 | 35976430 | Comorbidities complicating heart failure: changes over the last 15 years. | Clin Res Cardiol | 2023 | https://conductscience.org/library/papers/35976430 | PubMed |
| 18 | 24890535 | Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. | Am Heart J | 2014 | https://conductscience.org/library/papers/24890535 | PubMed |
| 19 | 34085774 | Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction. | ESC Heart Fail | 2021 | https://conductscience.org/library/papers/34085774 | PubMed |
| 20 | 19850699 | Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. | Circ Heart Fail | 2010 | https://conductscience.org/library/papers/19850699 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985515 | Review of Galectin-3 and the Collagen Marker PIIINP in Myocardial Fibrosis in Dilated Cardiomyopathy: Predictive Value for Major Adverse Cardiovascular Events. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42985515 | PubMed |
| 42774454 | Recent advances in biomarkers for cardiac fibrosis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42774454 | PubMed |
| 42653479 | The Clinical Value of NT-proBNP, sST2, and Galectin-3 in the Management of Heart Failure: From Diagnosis to Dynamic Monitoring: A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653479 | PubMed |
| 42299347 | Myocardial fibrosis and viability: the role of imaging and biomarkers in patients with chronic total occlusion on coronary angiography. | Biochem Med (Zagreb) | 2026 | https://conductscience.org/library/papers/42299347 | PubMed |
| 42194704 | Myocardial Fibrosis in Cardiovascular Disease: An Integrative Biomarker-Imaging Framework Linking Molecular Mechanisms to Structural Phenotypes. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194704 | PubMed |
| 41784746 | Silent Myocardial Infarction Revisited: Immuno-metabolic Mechanisms, Multimodal Biomarkers, and Translational Diagnostics. | J Cardiovasc Transl Res | 2026 | https://conductscience.org/library/papers/41784746 | PubMed |
| 40958744 | Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40958744 | PubMed |
| 40908522 | Therapeutic Targets for Myocardial Fibrosis: A Comprehensive Review of Current and Emerging Approaches. | Cardiovasc Hematol Disord Drug Targets | 2026 | https://conductscience.org/library/papers/40908522 | PubMed |
| 40747108 | Tracing the Rise of Galectin-3: A Global Bibliometric Insight Into Its Role in Heart Failure. | Int J Vasc Med | 2025 | https://conductscience.org/library/papers/40747108 | PubMed |
| 40399739 | Cardiac magnetic resonance and genetics in pediatric heart failure patients with nonischemia: prognostic implications. | World J Pediatr | 2025 | https://conductscience.org/library/papers/40399739 | PubMed |
| 39155333 | Association of fibrotic markers with diastolic function after STEMI. | Sci Rep | 2024 | https://conductscience.org/library/papers/39155333 | PubMed |
| 38736671 | Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial. | Int J Gen Med | 2024 | https://conductscience.org/library/papers/38736671 | PubMed |
| 37767953 | Evaluation of right ventricular diastolic function, systolic function, and circulating galectin-3 concentrations in dogs with pulmonary stenosis. | J Vet Intern Med | 2023 | https://conductscience.org/library/papers/37767953 | PubMed |
| 37685918 | The Role of Galectin-3 in Heart Failure-The Diagnostic, Prognostic and Therapeutic Potential-Where Do We Stand? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37685918 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| GDF15 | 9518 | PubTator's text mining | https://conductscience.org/library/genes/9518 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
| ST2 | 6761 | PubTator's text mining | https://conductscience.org/library/genes/6761 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979345
GET https://conductscience.org/api/papers/v1/36979345/references?page=2